USA View Profile
Cardiovascular; Metabolic and Internal Medicine within a Diabetes and Heart disease treatment and a prevention of complications
Sergey Zhuplatov is a successful Medical Scientist, the leader with a Metabolic/ CV Medical Affairs and Medical Development experience within the Global pharmaceutical industry. He was graduated in Russian Izhevsk State Medical Academy. After a fellowship in Internal Medicine and Endocrinology he completed Ph.D. dissertation in Cardiology with the Topic “Prevention of the Ischemic Heart Progression in Diabetics by extracorporal purification methods”. He practiced Endocrinology and Internal Medicine being a Clinical Assistant Professor for 12 years. He emigrated to the USA in 2002 and continued his scientific work as a preclinical scientist in the University of Utah Medical School. He published several scientific manuscripts in the area of Transplantology and Oncology at this time. However, he changed his job in 2008 and started his career in Pharmaceutical Industry. He is working as a Medical executive in the different area of CV/Metabolic Medical Affairs within a Strategy and Development of Anti-Diabetic drugs. He use his significant experience in Academic and practical Medicine for a better pharmaceutical support to patients with a different pathology.
University of South Alabama
USA View Profile
Professor Sjöholms research aims to clarify the molecular pathways that regulate insulin secretion, growth and death by the insulin-producing pancreatic islet β-cell, and why this goes awry in diabetes. More recently, in an effort to enhance endogenous production of glucagon-like peptide-1 (GLP-1), he has applied the same approach to study GLP-1-producing enteroendocrine L-cells. Another line of his research concerns translational and clinical studies of macrovascular complications of diabetes (myocardial infarction and stroke) with specific attention to pathogenic factors and therapeutic possibilities. His group was the first to show that GLP-1 ameliorates endothelial dysfunction in diabetic patients with stable coronary artery disease. He has since pursued these tracks mechanistically in animal models and in human coronary artery endothelial cells in vitro.
Ake Sjoholm is Adjunct Professor, College of Medicine, University of South Alabama, AL, U.S.A. (since 2003) and is also board-certified senior clinical consultant in internal medicine (since 1998). He has been active in experimental and clinical diabetes research for the past 30 years. He has published some 150 full papers in top international journals (Lancet, Science, PNAS, JBC, Diabetes, JCI, etc.) in this area and has received several national and international diabetes awards. He has been the chief supervisor of 10 completed Ph.D. programs.
Cardio Metabolic Institute
USA View Profile
Endocrinology; Osteoporosis; Metabolic Bone Disease; Vitamin D; Nutrition; Pharmaceuticals; Peptides; Peptide Receptors; Bone Mineral Density/DXA; Micronutrients; Obesity; Type 2 Diabetes
Dr. Wimalawansa is a university professor of medicine and chief of Endocrinology, Metabolism and Nutrition, and the director of the regional osteoporosis center, at the Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital in New Brunswick, New Jersey. He also served as a professor of physiology and integrative biology and pharmacology, Graduate School of Biomedical Sciences at the University of Medicine and Dentistry, New Brunswick, New Jersey and professor of general internal medicine & pharmacology at the UTMB Galveston. He holds numerous positions as an educator, author, researcher, innovator, executive board member, an administrator and philanthropist. He received multiple awards, including young investigator awards from several professional societies, The Dr. Boy Frame Award for Clinical Excellence in Metabolic Bone Diseases (1993), American Endocrine Society Glen Foundation Awards, and an innovation award from the Asian Chamber of Commerce (2000). In 2005, he received a coveted Lifetime Achievement Award from the Sri Lanka Foundation, Los Angeles, California, for his contributions to science, humanity and society. The International Society for Clinical Densitometry awarded him the 2007 Dr. Oscar Gluck Humanitarian Award. He has served on several national and international scientific review committees, including the NIH, VA, DEA, and NASA. In addition to publishing 168 peer-reviewed articles, 45 reviews and proceedings, 15 book chapters, 8 books, and holding 5 medical patents, he has delivered over 190 invited national and international lectures, over 350 scientific presentations worldwide, and numerous non-medical lectures. He is a regular reviewer for several national and international scientific journals and serves on several editorial boards.
Sanford School of Medicine
USA View Profile
Metabolic diseases; Endocrinology; Metabolic disorders; Metabolic control; Metabolic fitness; Cardiovascular diseases; Renal diseases; Bone diseases; Musculoskeletal diseases; Inflammatory diseases; Autoimmune diseases; Pediatric diseases; Nutrition; Type 2 diabetes; Type 1 diabetes; Obesity; Regeneration; Drug discovery and development; Translational research; Clinical research; Personalized medicine
Dr. Paul Burn is a successful senior scientist, leader and business executive with a lifelong mission, focus and passion of improving the human condition by delivering products, cures and care to patients and their families. As a senior executive with extensive global industry and international management experience, he has a proven track record of success in Academia, Pharmaceutical R&D, Biotech, Not-for-Profit and Integrated Health Care organizations. He designed and implemented multiple patient-centric projects which resulted in successful basic and translational research and development programs, in the pharmaceutical, nutrition, diagnostic, personalized medicine, treatment and cure areas. With over 30 years of experience in pharmaceutical and nutritional R&D and academia, he spearheaded many programs, from the gene to the clinics and through marketed products in the Endocrine, Metabolic Diseases, Cardiovascular, Renal, Bone, Musculoskeletal, Inflammation, Autoimmunity, Neuroscience, Dermatology, Oncology and Women�s Health therapeutic areas. Under his leadership multiple programs resulted in the successful identification of clinical candidate molecules, their evaluation in humans and subsequent market introduction. Most recently he served as Professor of Pediatrics at the Sanford School of Medicine of The University of South Dakota and as Scientific Founder, CEO and President of Metabolic Health & Fitness. In addition, he was the acting Chair and Director of The Sanford Project at Sanford Health, the largest rural health care provider in the US. He also serves on several Boards and Scientific Advisory Boards of Universities, Biotech companies and Government agencies. He served in the position of Senior Vice President of Research & Development at the Juvenile Diabetes Research Foundation (JDRF); at Hoffman-La Roche as the Global Head for the Metabolic Diseases Therapeutic Area and as Vice President of Biotechnology; at Eli Lilly & Company where he performed as the Vice President of Endocrine Research & Clinical Investigation; as Vice President of Research & Development for the Nutrition division at Monsanto/Pharmacia; and as Vice President of Metabolic Disease Research & Development at Bayer Health Care. Previously, he held positions at various academic institutions, including the University of California, San Diego, CA and the University of Basel, Switzerland. He authored more than a hundred articles in some of the most prestigious scientific journals.
Gregg Van Citters
USA View Profile
• Interaction of physiologic and pathologic microbial signals with the host genome. • Etiology, (patho) physiologic signaling and management of chronic inflammatory conditions including inflammatory bowel disease, obesity, diabetes, and atherosclerosis. • His current research interests focus on the connection between nutrition, the microbiome and health and pathophysiology.
Gregg Van Citters earned undergraduate degrees in Chemistry and Mathematics before working as a systems engineer in the laboratory automation field. He went on to earn a graduate degree in Human Nutrition while conducting clinical studies in gastroenterology and human nutrition at Cedars-Sinai Medical Center. Those successful studies led to his earning a doctorate in Physiology & Biophysics at the University of Southern California, where his research focused on neuroendocrine signals driving compensation for hyperinsulinemia in models of Type 2 diabetes and obesity. He spent several years as a postdoctoral fellow and assistant research professor in small molecule drug discovery at City of Hope National Medical Center before moving into the medical device industry to work in clinical research. At Medtronic he earned his Black Belt in Lean and Six Sigma process improvement and certified as a Master Change Manager. His expertise at understanding and engineering effective systems launched his most recent efforts in managing product safety for Medtronic Diabetes and now Beckman Coulter. He has published a number of papers and textbook chapters in gastroenterology, nutrition, diabetes and obesity.
USA View Profile
James H Anderson
USA View Profile
American Association of Diabetes Educators
USA View Profile
National Institute of Health
USA View Profile
Neuroendocrinology mainly on pituitary, adrenal tumor and new genetic mutations; Medical education; Case report in endocrinology; Evidence based medicine in endocrinology; Melatonin
Ricardo Correa, MD, Es. D, is a clinical and research endocrinology fellow at National Institute of Health, member of the ACGME internal medicine resident review committee and member of the national board of medical examiner medical school program committee. He completed his Medical School and Education Master at University of Panama. Before going on training, he completed a research fellowship in Epidemiology and Tropical disease at Gorgas Memorial Institute for Health Studies in Panama City. He completed his internal medicine residency at Jackson Memorial hospital-University of Miami program as part of the William Harrington Program and during his residency he was instructor of Medicine for the University of Miami. In 2012, he was honored with the Alpha Omega Alpha from the University of Miami. He was trained in Evidence-based medicine at McMaster University in Canada and in Editorial process and Open Journal system by LATINDEX. He is co-director of the Panamanian Cochrane Center and Evidence Based Medicine advocate. He has been involved in organized medicine since medical school. He has been president of the Latin American Medical Student Association (FELSOCEM), scientific committee chair and actual vice speaker for the American medical association resident and fellow section, chair of the council of resident for the American College of Physician Florida Chapter, National Secretary of the Council of Resident of the National Hispanic Medical Association, Regional Vice President of the Committee of Intern and Residents, Medical Education Officer of the Junior Network Developer of the World Medical Association, among others. He has been involved in multiple academic and educational activities including article Consultant, Interpretation of the Medical Literature Project, National Board of Medical Examiners, International Committee member of the Committee on publications ethics (COPE), MORE, McMaster rater and evaluator of evidence based-Medicine articles, Dynamed reviewer, Deputy Editor of International Archives of Medicine, Editorial board of the International Journal of Case Report and Imaging, Editorial Board of Internet Medical Publishing and Editorial Board as advisor of International Journal of Medical Students. Also peer reviewer for the Panamerican Journal of Public Health (PAHO journal), Journal of Translational Medicine, and Journal of General Internal Medicine (JGIM). He was the Fellow-in-training board of director for the AACE during 2014-2015 period, In 2012, he received the Gary F. Izzo scholarship award from the ACP Florida Chapter and The North America Menopause Society/Pfizer Medical Resident and Fellow Reporter Award. In 2013, he received the Eric Reiss Internal Medicine Award from the University of Miami and the GOLD DOC award for Humanistic doctor. He is the author of the book title �Case report: basics and publication�. He is interest in neuroendocrinology and melatonin metabolism and function.
USA View Profile
With her involvement at both clinical and community level, she is interested in developing effective mechanisms to improve the health outcomes specially regarding chronic disease management (diabetes, obesity and cardiovascular disease) through patient education at several levels including clinical encounters, community outreach and self-management that can then together positively impact the quality of their care and keep them healthier for a lifetime.
Inuka Midha has been providing several opportunities of real world hands on training for her undergraduate global health students by forming independent academic collaborations with refugee and immigrant resettlement agencies, community organizations, Georgia State & local (DeKalb County) health departments as a Visiting Assistant Professor at Emory University since 2009. The seminar courses she designs and teaches ensures that we are all able to contribute to developing healthy communities, thus achieving the Institute of Medicine�s (IOM�s) vision of eliminating health disparities by reaching out to some underserved populations in our area. The goal of the health workshops she conducts in the communities is to understand culture specific barriers and to disseminate pertinent health information to the communities involved and increase their self-awareness of specific health issues affecting its members. She has received numerous awards including two University Gold Medals from University of Delhi in India in 1993 and 1995 for Bachelors and Masters Program in Anthropology, All India Junior and Senior Research Fellowship from University Grants Commission, a post doctoral fellowship in Applied Biological Anthropology from Council for Scientific and Industrial Research in 2000. Recently she received the highly prestigious 2013 Open Society award by the Society for Public Health Education for her commitment to research, practice and teaching for developing innovative programs through community collaborations and developing unique strategies to address the barriers and gaps in population health at the level of our local communities. As a current patient care and community engagement coordinator at a primary care medical clinic in Atlanta Georgia, she continues her mission of identifying and addressing the unique barriers and health needs of rapidly growing diverse population groups of immigrant communities in the United States.
USA View Profile
ST. Panteleimon Hospital
Bulgaria View Profile
Diabetology; Endocrinology; Clinical nutrition; Metabolic diseases; Heart rate variability in diabetics; Metabolic syndrome; Cardiology and other areas of the internal medicine; Neurovegetology; Phytotherapy; Anti-aging medicine
Dr. Ivan Domuschiev is born 1961 in the town Panagiuriste. He graduated the German Language School “Bertold Brecht” in Pazardjik City with fully excellent marks and a medal. He graduated in 1986 the Medical University in Plovdiv city with fully excellent marks as promotor of the course (speciality“medicine“). He defended a dissertation with a conference on the scientific degree “Philosophy Doctor in Medicine” (Ph.D.) in the field of the endocrinology (diabetology). He was long time Assistant-Professor in internal diseases and endocrinology as well as he leaded clinical exercises in postgraduated teaching. He worked as Assistant-Professor at the Clinic of Endocrinology – Medical University in Plovdiv, Clinic of Endocrinology- Medical Institute- Central Clinical Base in Sofia, National Sport Academy in Sofia. He has 82 scientific publications, whereof 8 scientific monographies, 1 practical handbook for diabetics, as well as great number of participations at scientific symposiums and congresses in Bulgaria and foreign countries. He has own scientific investigations in the field of the heart rate variability (HRV) in patients with various diseases. He specialized in the area of endocrinology and diabetology in Moscow by Acad., Prof. M.D.I. Dedov, in Germany and Vienna by the well-known endocrinologist Prof. Michael Roden. He specialized in Moscow iridology by Prof. Verlhover and non-contact massage by Juan. He finished a course “Introducing in Good Clinical Practice” - lecturer Sue Fiztpatrick from the Institute of Clinical Research, London, as well as other courses in endocrinology and internal diseases. He specialized health management. He is a fellow of Bulgarian Society of Endocrinology, Bulgarian Association of Diabetology, German Society of Diabetology, Austrian Society of Diabetology and European Society of Antiaging Medicine (ESAAM). He works at the present time as an endocrinologist in the Department of Internal Medicine at Multiprofile Transport Hospital in Plovdiv City. He worked previously as an endocrinologist in the II. Department of Internal Medicine at Multi profile Hospital “St. Panteleimon” (about 3 years) and in the Private Clinic “Medicus Alpha“ in Plovdiv city and he led the Direction „Ant-aging Medicine“ in the same clinic and in Medical Holding „United Medical Group“ for 4,5 years.
Consultorios Integrados Rosario
Argentina View Profile
France View Profile
Obesity; Diabetes; Lipidemia; Metabolic disorder; Drug discovery; Target identification; Target validation
Dr Itzik Harosh is the founder & CEO of ObeTherapy (January 2000 - present) a biotech dedicated to the discovery of new genes for obesity and diabetes treatment based on the lean phenotype and the development of molecules for the treatment of metabolic syndrome. Establish the concept to look for new genes associated to starvation phenotype based on rare genetic diseases for the treatment of obesity and type II diabetes. Prior to the creation of ObeTherapy he was a Group leader in GSK in France where he learned the art of drug discovery, targets identification and validation. He did his PhD at The Weizmann Institute of Science, Rehovot, Israel, working on DNA repair enzymes (1982-1987) which was followed by four years of post doctoral experience at Stanford and at Davis University, California, USA. (1987-1991) from there he moved to France where he worked in the CNRS at the laboratory of Miro Radman. From there moved to the Glaxo Welcome where he learned the art of drug discovery and target identification a validation. He is the author and co-author of 15 articles and 8 patents all dealing with obesity, diabetes and HTS. He is on the editorial board of: Journal of Biotechnology and Bioengineering (2014), International Journal of Diabetes & Clinical Diagnosis (2014), Advances in Obesity, Weight Management & Control (2014), Jacobs Journal of Bioinformatics and Proteomics (2014). He is regularly invited to international Obesity, Diabetes and metabolic syndrome conferences.
Tohoku University Hospital
Japan View Profile
Serotonin network; GLP-1 network; Feeding regulation; Hepatic glucose and lipid metabolism; Medical device in the treatment of Diabetes and Hypertension
Dr. Katsunori Nonogaki is a specialist of Diabetes care and Internal medicine. He has obtained PhD in Endocrinology, Metabolism and Diabetes. Then, he worked as a Postdoc Fellow at the University of California, San Francisco and the Scripps Research Institute, La Jolla. During this period, his research has mainly focused on “the role of the central nervous system in the regulation of hepatic glucose production”, “cytokines and lipid metabolism” and “brain serotonin systems and energy homeostasis”. He found the novel evidence in the dissociated pathways of serotonin 5-HT2C receptor and leptin in the central regulation of appetite and obesity, and proposed a novel physiological theory of “central dissociated regulation of feeding and autonomic neural circuits”. Current studies are to determine the physiological mechanisms and potential treatment for obesity, diabetes and their complications. He is also developing novel medical devices for hypertension and diabetes.
Canadian Diabetes Association
Canada View Profile
Portuguese Institute of Oncology
Portugal View Profile
He has completed some courses and specific stages in Diabetology and Endocrinology areas, with experience in both Gestational and Pregestational Diabetes; Secondary Diabetes (corticosteroid-induced or after pancreatic surgeries); Type 2 Diabetes; as well as with Metabolic Abnormalities in Polycystic Ovarian Syndrome.
Pedro Marques M.D. is a young endocrinologist currently at Portuguese Institute of Oncology, Lisbon, Portugal. He is a member of some relevant national and international societies: Portuguese Society of Endocrinology (Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo, SPEDM), Portuguese Study Group of Adrenal Tumors from the SPEDM, European Society of Endocrinology and The Endocrine Society. He gave several presentations at National and International level. He also conducted some other works in different endocrine areas, mostly in the oncological field, such as thyroid cancer, neuroendocrine tumors and pituitary tumors. He has some national and international publications.
Muhammad Asif Memon
Sulaiman Al Rajhi Colleges
Saudi Arabia View Profile
Medical Writer Freelance
Italy View Profile
His professional practice has focused on Diabetes; Metabolism; Obesity; Pharmacology; Neurology; Biochemistry and Immunology correlated to pre-clinical research included data analysis. He has experience on health risks associated with exposure to chemicals and radio-isotopic in workplace and environment, also biohazard.
Piero Chiodi is an Italian Biologist Medical Writer free-lance with strong Life Science background in the pharmaceutical industry with close relationship to academia. He had born 12 June 1958 at Fabriano (AN), in the Marche region (Italy). In the 1977 he obtained the degree of Industrial Chemistry Expert in the Secondary-school-leaving, G. L. Bernini in Rome. In the 1986 he obtained the Degree in Biological Sciences (PhD), from University of Rome, while in the 1995 he obtained the official State certificate for Biologist practice qualification from Rome University. As Senior Scientist Manager he gave his own contribute for the successful development of a several drugs. He has an extensive range of scientific and professional contributes summarize in 14 papers; 6 oral communications; 29 meeting abstracts; 22 conferences, workshops, guest lectures, particularly important for the contribute at knowledge metabolic mechanisms related to carnitine role as well as two important industrial patents [U.S.A. patent no. 09 / 677.328 (1999) and no. 6,444,701 (2002)]. He has experience on laboratories management and safety- biohazard training. Solid knowledge of cGMP, GCP, GLP, HACCP, ISO standards and management systems, strong experience in pre- clinical study reports and clinical submission documents (IBs, INDs, NDAs) with critical review and statistical analysis of non-clinical and clinical data. Engaged on 1984 in an Italian pharmaceutical company, sigma-tau spa (Rome, Italy), for 3 years until 1986 he was technical specialities with aim to set-up complex analytic, enzymatic and radiochemistry methods with particular regard to lipoproteins. On 1990 he was guest researcher at Department of Human Physiology, Medicinal Faculty of Naples’ University, while on 1992 he attended the Elba Summer School in Neurobiology of Neurological Disabilities, organized by Colorado University, Denver, CO, USA. For 10 years until 1996 he was head of Lipid Metabolism Laboratory and responsible for 6 staff covering scientific and technical specialities with management of pre-clinical studies on anti-lipemic and anti-aging drugs. In team-work with Erasmus University, The Netherlands, he demonstrated the hypolipemic effect of L-carnitine on plasma lipoproteins in hyperlipemic fat loaded rats (Lipids 1987; 22 (12): 1005-1008); with UCLA University, CA, USA, he demonstrated acetyl-l-carnitine treatment in demyelinated rat model has an important role in myelin synthesis in oligodendrocytes (Int J Dev Neurosci 1992; 96: suppl.) and with Colorado University, Co, USA, he demonstrated, at first time in the chick embryo, a diversified role of carnitines in neurogenesis during axonal extension and synaptogenesis (Int J Bioch 1994; (26)5: 711-720). As high expertise on kinetic enzymatic studies he demonstrated the tissue lipid accumulation by inhibition of carnitine-palmitoyltransferase-2 (CPTII) calculating, at the first time, the fifty per cent inhibition value (Ic50) of L- aminocarnitine (Biochimica et BiophysicaActa 1992; 1127: 81-86). During 1991, he was transitory Biochemistry Department responsible for 25 staff covering all scientific and technical specialities. On 1999 he attended the course on Valorization and Management of Human Resources, organized by Watson Wyatt Isso, Rome. For 4 years until 2000, he was head of Enzymology and Biochemistry Protein Laboratory and Biological Hazard Laboratory (level three biological risk) with management of complex pre-clinical studies on compounds proposed as anti-aging and as anti-diabetic drugs tested on type I and type II diabetes animal models which results of new drugs proposed as anti-ketotic and anti-diabetic agents (J Med Chem. 2001, 19; 44(15): 2383-2386; J Med Chem. 2003; 46 (2): 303-309) followed in pipeline as oral hypoglycemic; He managed also basic studies on enzymatic and metabolic pathways carnitine-system implicated in diabetes (Journal of Peripheral Nervous System 1996; vol. 1(2):157-163), and in neuropathy diabetes-related. On May 2000 until December 2015 he had the chance to following pre-clinical drugs-pipeline preparing experimental reports for Biochemistry, Immunology, Pharmacology and Neuropsychology sectors in R&D with statistical pre-clinical data elaboration by means statistical tests and pre-clinical dossiers (IBs, INDs) for Biochemistry (Teglicar®) and for Immunology (AvidinOX® and Tenatumomab®) as Technical and Scientific Writer (US Professional Center Certification) without neglect laboratories. In fact, in 2009 he was also charged of Radioisotopes Laboratories Head (D.lgs 230/1995 and D.lgs 241/00, Italian laws) providing staff training (3-4 courses/yr), increasing staff safety and protection (16 new SOPs releasing) and saving about 10-12,000 Euro/yr on budget laboratory. On June 2013 he obtained from Trinity College London the Esol Certificate in English level B2 CEFR. During the years 2014 and 2015 he attended at several qualification courses: School for writers - Borders Connect, UK obtained License No. BC09145; Advanced Courses of Pharmacovigilance, Clinical Monitor, Regulatory Affairs and Quality Assurance, GMP, Biological Risk on work Environments and several Mastery from UL-FDA on Quality Risk Management (ICHQ9) (ISPE09), on GxPs (PHDV61), on Application of GMP to Microbiology Laboratories (PHDV72-EU), on Environmental Control and Monitoring (PHDV87), on Documenting the Drug Development Process (ICHQ8) (ISPE07), all Computer Based Training. On January 2015 up to now is a Medical Writer Freelance for approval process for drugs, medical devices and biologics with management of study plans, reports and dossiers (IBs and INDs). He’s a member of Italian Society of Pharmacology; CROs Medical Writer Consultant, organizer and chairman of local scientific symposium and meetings.
Nigel Ten Fleming
InKemia IUCT Group
Spain View Profile
Joaquin Perez Guisado Rosa
University of Cordoba
Spain View Profile
Nutrition and Metabolism; Weight Loss; Sport Medicine; Pharmacology and Plastic; Reconstructive and Aesthetic Surgery.
Dr. Joaquin Perez-Guisado Rosa studied Veterinary (2000) at the University of Córdoba (Spain) and Human Medicine and Surgery (2004) at the University of Granada (Spain). He got the PhD in Veterinary at the University of Córdoba (2004, Spain) and the PhD in Medicine and Surgery (“Nutrition and Metabolism” doctorate program) at the University of Córdoba (2014, Spain). He was the Medical Director (2005-2008) at a pharmaceutical laboratory (Laboratorios Pérez Giménez., Córdoba, Spain). He got 4 certifcates on National Personal Trainer of Bodybuilding and Fitness (2002, Spanish Association of Bodybuiliding and Fitness, AEF), Homeopathy (2006, Homeopathy institute of Cataluña, Spain), Phytotherapy (2006, Spanish Association for Continuing Education in Health Sciences and Education, Jaén, Spain) and Animal Experimentation (2008, Junta de Andalucía, Spain). He has 2 Master Degrees: in Sport Medicine (2006, Spanish Association for Continuing Education in Health Sciences and Education, Jaén, Spain) and Pharmacovigilance and Postauthorization studies (2007, University of Sevilla, Spain). He finished the Medical Specialty of Reconstructive, Plastic and Aesthetic Surgery (2013) at the University Hospital of Reina Sofia (Córdoba, Spain). He discovered and published the weight loss program internationally known as “Ketogenic Mediterranean diet”. He has published 40 scientific articles, 29 scientific communications and has been Guest Speaker 2 times. He is member of the editorial board of the international journals “RECVET”, "International Journal of Burns and Trauma", “Obesity and Control”, “Obesity and Control Therapies”, “Plastic and Aesthetic Research”. Actually he is Honorary Collaborative Professor at the Genetic Department at the University of Cordoba (Spain) and is working as a Plastic surgeon and Physician specialist in weight loss in several hospitals.
Spain View Profile
Im working on research the application of new technologies to help improve healthy habits, to improve the quality of life of patients, make early diagnosis of diseases such as Diabetes; Obesity and metabolic syndrome; Personalized treatments to help patients to better cope with their chronic diseases; Improve quality of life and facilitate their treatment; Providing care and education for health
Nicolas Rufino MD. MSc. Specialist in Nutrition and Diabetologia, Sports Medicine, Farmacoclinica, Master in Nutrition at the University of Barcelona, is currently working on the Garraf Healthcare Consortium Sant Antoni Abat Hospital, Barcelona, Spain. Catalan Institute of Health, General Medical Council, UK. He participated in academic activities at the University of Buenos Aires as Deputy Assistant Professor in the Department of Clinical Nutrition, and Pathology at the National University of Tucuman. He is a member of some relevant national and international companies in the area of Nutrition and Diabetes. He gave several presentations at national and international level. He also made some other works in different areas Diabetes and Physical Activity, especially in the field of new technologies for early diagnosis, improved controls and treatment of diabetes and its complications. He participate in as editor in Journals in the US and Germany. Atheneum consultant in national and international publications (Atheneum, Bio Accent - BAOJ Diabetes Journal - Editorial Board office). He collaborated Diabetes Foundation in Spain, with diabetics participating in the half marathon, Medical Foundation Special Olympics Spain contributor, Senior Medical FINA world swimming Barcelona 2013, and medical volunteer 2012 London Summer Olympics Games. He always is looking for new procedures to help improve the quality of life of patients.
Jaime Ruiz Tovar
University Hospital Rey Juan Carlos
Spain View Profile
Jaime Ruiz-Tovar, MD, PhD, is General and Digestive Surgeon at University Hospital Rey Juan Carlos (Madrid-Spain), where he is specialized in bariatric surgery. Professor of Surgery at Universidad Rey Juan Carlos. Secretary of the Surgical Infections Section of the Spanish Surgical Society. Head of the Bariatric Surgery section of the ERAS-Spain group (Enhanced Recovery after Surgery). He actually leads several investigational projects focused on bariatric surgery and surgical infections.
National Autonomous University of Mexico
Mexico View Profile
Oman View Profile
The relationship between vitamin D and type 2 diabetes; The relationship between probiotics and diabetes; The association between physical activity and obesity; The use of herbs such as rosemary in treatment of diabetes and high cholesterol level.
Prof. Louay Labban has completed his PhD from La Sale University in the USA in 1995 on the effect of polyphenols and isoflavones on the immunomodulation therapy. His postdoctoral studies were done at Lund University in Sweden. He finished his M.Sc from University of Newcastle upon Tyne in England. He has been a professor of clinical nutrition at A’Sharqiyah University in the Sultanate of Oman since 2014. Before that, he taught different nutrition courses in several universities in the USA in addition, he also worked for well-known pharmaceutical companies as a head of nutrition assessment team studying the effect of newly developed medications on the nutritional status of patients. He has published more than 25 papers in reputed journals and has been serving as an editorial board member of scientific journals. He is affiliated with American Overseas Dietetic Association (AODA).
King Georges Medical University
India View Profile
Rajendra Nath is working for the Department of Pharmacology (KGMU) since -1987. He was involved in Opioid receptors in Central Nervous System as a part of his thesis. Then from 1997 to 2000 as Research Associate, Awarded by Council of Scientific & Industrial Research –CSIR of New Delhi & involved in receptor research for cardiovascular regulation & development of New CNS active agents. Presently from 2002 till now he has been working in KGMU in Department of Pharmacology & Therapeutics as Faculty on various posts till him finally became Professor in December 2010. The Present area of his research work is: 1. Neuro –cardiovascular-pharmacology & Study of Heavy metal (Lead) toxicity of Brain (with the help of financial grant from ICMR –New Delhi). 2. Research & development of drugs from useful Medicinal Plants mainly for cardiovascular diseases which are taking an epidemic form in our Country and abroad e.g.-Diabetes mellitus (in collaboration with CIMAP, Lucknow), Hypertension, Hyperlipidemia leading to cardiovascular diseases. From above work he has published many research articles in National & International Peer Reviewed Indexed Journals of high repute. Apart from this he have been actively involved in Teaching & Training of UG (MBBS & BDS) & PG (MD, MDS & PhD) students & Guided/ Co-guided many of their thesis. He has also Co-authored the book entitled “MCQs in Pharmacology”. He has been conferred with Bharat Jyoti & Indira Gandhi Shiromani award for his work. He is a member of various Organizations & important Committees in our University.
October Six University Hospitals
Egypt View Profile
Shehab M. Abd El-Kader
Egypt View Profile
Physical Therapy for Metabolic Disorders , Cardiopulmonary Disorders, Cardiovascular Disorders Geriatrics, Wound Care and Women Health.
Prof. Shehab Mahmoud Abd El-kader, PT, MPT, PhD in physical therapy for cardiopulmonary, metabolic,women health, and geriatrics, Faculty of Physical Therapy, Cairo University, Egypt, since 2000 . Recent research interests include the areas of Metabolic Disorders , women health, caring for older people, cardiopulmonary disorders, geriatrics, hepatology and wound care. Prof. Shehab is interested in teaching Physical therapy for patients with respiratory disorders, geriatrics, hepatology and metabolic disorders. In addition, he has published several original researches in refereed pioneer journals, published ten online textbooks with LAMBERT Academic Publishing in Germany that are available in Amazon and participated in many international conferences all over the world. Prof. Shehab is a designer and reviewer for several teaching curriculum for bachelor and master degrees in physical therapy for many universities in the middle east. Also he is a reviewer for many medical and scientific journals in addition to be a supervisor and referee for several post-graduate scientific thesis, he is an editorial board member for many international Journals. Finally, Prof. Shehab has a long history in teaching for students in the bachelor, master and doctorate degrees in physical therapy.
The University of Zanjan
Iran View Profile
Veterinary; Animal Agricultural; Economical; Educational; Medical; Biological; Microbiological; Biochemical; Genomic; Proteomic and Metabolomic; Pharmaceutical; Biotechnological; Animal Agricultural; Nanotechnological; Humanities and Arts; Managerial; Medical; Physiological; Nutritional; Nanotechnological; Medicinal; Microbiological; Economical; Veterinary; Chrono biochemical; Psychological; Social; Philosophical; Linguistic; Biochemical and Biophysical; Immunological & Pathological; Lingual; Public Health; Basic Sciences
Professor Akbar Nikkhah holds BSc in Animal Sciences (University of Zanjan, Iran,1999), MSc in Animal Nutrition (Isfahan University of Technology, Iran, 2001), PHD in Dairy Nutritional Physiology (University of Manitoba, Canada, 2007) and PostDoctorate in Nutritional Genomics and Management (University of Illinois, US, 2008). Dr. Nikkhah has received numerous national and international awards & honors and authored > 40 books and book chapters and > 550 influential global scientific publications namely articles of scientific, industrial and outreach nature. Professor Nikkhah significantly influences upon and changes lives of countless people, mentees, mentors, groups, industries, universities, schools, and global institutions in accomplishing resourceful economy and quality life. He speaks in a variety of national and international conferences and meetings and serves > 500 national and international journals, conferences, and publishers as chief science advisor, editor and evaluator. He serves the global community as Chief Highly Distinguished Professor and Mentor and Frontier Highly Distinguished Peace Leader with diversified programs in multidisciplinary and interdisciplinary science and technology research and education.